Alexander Vasilyev

5.3k total citations · 1 hit paper
3 papers, 284 citations indexed

About

Alexander Vasilyev is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Alexander Vasilyev has authored 3 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 1 paper in Rheumatology. Recurrent topics in Alexander Vasilyev's work include Urologic and reproductive health conditions (1 paper), Advanced Breast Cancer Therapies (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). Alexander Vasilyev is often cited by papers focused on Urologic and reproductive health conditions (1 paper), Advanced Breast Cancer Therapies (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). Alexander Vasilyev collaborates with scholars based in Russia, Spain and Canada. Alexander Vasilyev's co-authors include Junji Furuse, Alexandra Heurgué, Tu Van Dao, Kabir Mody, Alejandra Negro, Wattana Sukeepaisarnjaroen, Philip He, Masatoshi Kudo, Ghassan K. Abou‐Alfa and Vincent C. Tam and has published in prestigious journals such as Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Alexander Vasilyev

3 papers receiving 280 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.

2022 259 citations Ghassan K. Abou‐Alfa, Stephen L. Chan et al. Journal of Clinical Oncology profile →

Peers

Alexander Vasilyev

HEPAT

ONCOL

PRM

EPIDE

PFM

Yichuan Yuan China

Ziyu Xun China

Satheesh Chiradoni Thungappa India

Francesca Garuti Italy

Lorraine Blaise France

Petia Jeliazkova Germany

Mariella Di Marco Italy

Arteid Memaj United States

Xuqi Sun China

P Hilgard Germany

Yichuan Yuan China

Alexander Vasilyev

135 ×0.7

HEPAT

60 ×0.4

ONCOL

62 ×0.8

PRM

58 ×0.9

EPIDE

46 ×0.8

PFM

Citations per year, relative to Alexander Vasilyev Alexander Vasilyev (= 1×) peers Yichuan Yuan

Countries citing papers authored by Alexander Vasilyev

Since Specialization

Citations

This map shows the geographic impact of Alexander Vasilyev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Vasilyev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Vasilyev more than expected).

Fields of papers citing papers by Alexander Vasilyev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Vasilyev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Vasilyev. The network helps show where Alexander Vasilyev may publish in the future.

Co-authorship network of co-authors of Alexander Vasilyev

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Vasilyev. A scholar is included among the top collaborators of Alexander Vasilyev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Vasilyev. Alexander Vasilyev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Fasching, Peter A., Aditya Bardia, Vanesa Quiroga, et al.. (2022). Neoadjuvant giredestrant (GDC-9545) plus palbociclib (P) versus anastrozole (A) plus P in postmenopausal women with estrogen receptor–positive, HER2-negative, untreated early breast cancer (ER+/HER2– eBC): Final analysis of the randomized, open-label, international phase 2 coopERA BC study.. Journal of Clinical Oncology. 40(16_suppl). 589–589. 24 indexed citations

2.

Abou‐Alfa, Ghassan K., Stephen L. Chan, Masatoshi Kudo, et al.. (2022). Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.. Journal of Clinical Oncology. 40(4_suppl). 379–379. 259 indexed citations breakdown →

3.

Vasilyev, Alexander, et al.. (2015). Comparison of oncological results and functional outcomes of radical prostatectomy techniques – retropubic, laparoscopic and robot-assisted. SHILAP Revista de lepidopterología. 11(4). 54–58. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact